---
figid: PMC10121351__ECAM2023-1307323.008
figtitle: Schematic of the molecular mechanism underlying UA anticancer activity in
  NSCLC cells
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10121351
filename: PMC10121351__ECAM2023-1307323.008.jpg
figlink: /pmc/articles/PMC10121351/figure/F8
number: F8
caption: A schematic of the molecular mechanism underlying UA anticancer activity
  in NSCLC cells. UA treatment inhibited the EGFR/JAK2/STAT3 signaling pathway, leading
  to the diminishment of Sox-2, Oct-4, ABCG2, CD133, and C-Myc.
papertitle: Inhibitory Effect and Mechanism of Ursolic Acid on Cisplatin-Induced Resistance
  and Stemness in Human Lung Cancer A549 Cells
reftext: Luxin Fan, et al. Evid Based Complement Alternat Med. 2023;2023(NA).
year: '2023'
doi: 10.1155/2023/1307323
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi
keywords: ''
automl_pathway: 0.9426614
figid_alias: PMC10121351__F8
figtype: Figure
redirect_from: /figures/PMC10121351__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10121351__ECAM2023-1307323.008.html
  '@type': Dataset
  description: A schematic of the molecular mechanism underlying UA anticancer activity
    in NSCLC cells. UA treatment inhibited the EGFR/JAK2/STAT3 signaling pathway,
    leading to the diminishment of Sox-2, Oct-4, ABCG2, CD133, and C-Myc.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK2
  - STAT3
  - EGFR
  - EGF
  - SOX2
  - POU5F1
  - POU5F1P3
  - POU5F1P4
  - ABCG2
  - FOXD3
  - EGF
---
